/Companies

Aspicio Therapeutics

Downingtown, US · Founded 2024 · Delaware corporation

Find your way into Aspicio Therapeutics

Sign up to see every warm intro you have to Aspicio Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aspicio Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MK
Michael KeaneExecutive

Reported raises · per SEC filings

Form D private placements

$600K disclosed across 2 rounds · 2024–2026

▶$200KraisedJul 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael KeaneExecutive Officer, Director
Offering amount
$200K
Amount sold
$200K
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$400KraisedJun 2024 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael KeaneExecutive Officer, Director
Offering amount
$400K
Amount sold
$400K
First sale
Jun 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Aspicio Therapeutics raised?
Aspicio Therapeutics has disclosed $600K raised across 2 rounds.
Where is Aspicio Therapeutics headquartered?
Aspicio Therapeutics is headquartered in Downingtown, US.